NextPlat (NASDAQ:NXPL) Trading 6.5% Higher – What’s Next?

NextPlat Corp. (NASDAQ:NXPL) shares were up 6.5% during trading on Thursday . The company traded as high as $8.37 and last traded at $7.69. Approximately 59,910 shares traded hands during trading, an increase of 205% from the average daily volume of 19,660 shares. The stock had previously closed at $7.22.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

NextPlat Price Performance

The business has a fifty day simple moving average of $5.97 and a two-hundred day simple moving average of $5.92. The company has a current ratio of 2.56, a quick ratio of 2.12 and a debt-to-equity ratio of 0.05. The stock has a market cap of $20.84 million, a PE ratio of -1.78 and a beta of 1.90.

NextPlat (NASDAQ:NXPL) last posted its earnings results on Thursday, May 14th. The company reported ($0.42) earnings per share for the quarter. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%.The firm had revenue of $9.86 million for the quarter.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NextPlat stock. Citadel Advisors LLC bought a new position in shares of NextPlat Corp. (NASDAQ:NXPL) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat as of its most recent filing with the Securities and Exchange Commission. 1.30% of the stock is currently owned by institutional investors and hedge funds.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.